Vaccines : adverse events in women

According to the National Agency for the Safety of Medicines (ANSM), there is no direct link between vaccination against Covid-19 and menstrual disorders. This statement is contested by scientists including Jean-Marc Sabatier.

In a status update on Covid-19 vaccine surveillance published on December 21, 2021, the French National Drug Safety Agency (ANSM) writes, “To date, the available data do not allow for a direct link between the vaccine and the occurrence of these menstrual cycle disorders. These events remain under surveillance.”
Yet many women are finding the opposite to be true. And scientists are surprised by such a peremptory statement from the ANSM.

Responsible for coagulation disorders

Dr. Jean-Marc Sabatier*, in particular, demonstrates the opposite. He reminds us that “menstruation (menstruation) corresponds to the periodic flow through the vagina of a biological fluid made up of blood, vaginal secretions, and endometrial cells (uterine wall). Menstruation corresponds to the evacuation of the superficial layer of the mucous membrane of the uterus (endometrium) which had formed during the menstrual cycle to accommodate a possible fertilized egg. In the absence of fertilization, the surface of the endometrium (which is highly vascularized) is then evacuated through the vagina in the form of bleeding.
The SARS-CoV-2 spike protein binds to the ACE2 receptor of the target cells.
The endometrium and the vascular system consist of epithelial and endothelial cells that express the ACE2 receptor recognized by the spike protein.
This shows that the vaccine spike protein can act directly on the endometrium and associated blood vessels.

SARS-CoV-2 -via the spike protein- causes blood clotting disorders, including thrombocytopenia (a decrease in the number of blood platelets that help the blood clot).
Thus, the vaccine spike protein may be (not to say “is”) directly responsible for clotting and menstrual disorders.

ACE2 = angiotensin-2 converting enzyme

*Jean-Marc Sabatier, Director of Research at the CNRS and Doctor in Cell Biology and Microbiology, affiliated with the Institute of NeuroPhysiopathology (INP), at the University of Aix-Marseille. Editor-in-Chief of the international scientific journals: “Coronaviruses” and “Infectious Disorders – Drug Targets”.